Pharmaceutical Business review

Trinity Biotech names new CEO

Mr O’Caoimh will succeed Brendan Farrell, who has resigned with immediate effect, having served as Trinity’s president since 1994 and as CEO since November 2007.

Mr O’Caoimh said: “I am hugely excited by this challenge and, given our product offering and development pipeline, am determined to deliver on our enormous potential for enhanced shareholder value.”